BATON ROUGE, La., Feb. 26 /PRNewswire-FirstCall/ -- Albemarle Corporation, (NYSE: ALB) a global leader in providing innovative solutions to the specialty chemicals market, has rescheduled its investor conference from Thursday, May 13th to Tuesday, May 18th for logistical reasons. The event will take place at the St. Regis Hotel in New York City on May 18th, 2010, with presentations from 8:00 a.m. to 12:30 p.m ET, followed by lunch. Mark C. Rohr, Chairman and CEO, along with other members of the company's management team will provide an update on key business strategies and growth initiatives.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050801/ALBEMARLELOGO )
Additional event details, registration and agenda will be forthcoming and will be posted on Albemarle's website at http://www.albemarle.com.
The presentation and audio webcast will be made available live on Albemarle's website the day of the event at http://www.albemarle.com under Investor Information.
About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer, and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. The Company is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts, and Fine Chemicals. Albemarle employs nearly 4,000 people and serves customers in approximately 100 countries. To learn more, visit www.albemarle.com.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.
SOURCE Albemarle Corporation
Share this article